Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma. Related Content:
- Renal Cell Carcinoma
情報
- 番組
- チャンネル
- 頻度アップデート：毎週
- 配信日2024年8月28日 15:00 UTC
- 長さ21分
- 制限指定不適切な内容を含まない